Summit Global Investments Sells 15,369 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Summit Global Investments cut its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 95.9% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 657 shares of the company's stock after selling 15,369 shares during the quarter. Summit Global Investments' holdings in HCA Healthcare were worth $227,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently made changes to their positions in HCA. Brighton Jones LLC purchased a new stake in shares of HCA Healthcare during the 4th quarter valued at $1,021,000. OLD National Bancorp IN raised its position in shares of HCA Healthcare by 28.5% during the 4th quarter. OLD National Bancorp IN now owns 997 shares of the company's stock valued at $299,000 after buying an additional 221 shares in the last quarter. Mediolanum International Funds Ltd grew its holdings in HCA Healthcare by 0.3% in the 4th quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company's stock worth $3,153,000 after acquiring an additional 36 shares during the last quarter. Capital Insight Partners LLC grew its holdings in HCA Healthcare by 15.0% in the 4th quarter. Capital Insight Partners LLC now owns 3,658 shares of the company's stock worth $1,098,000 after acquiring an additional 477 shares during the last quarter. Finally, Tokio Marine Asset Management Co. Ltd. grew its holdings in HCA Healthcare by 437.0% in the 4th quarter. Tokio Marine Asset Management Co. Ltd. now owns 29,154 shares of the company's stock worth $8,751,000 after acquiring an additional 23,725 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

HCA Healthcare Price Performance

HCA Healthcare stock traded up $0.49 during mid-day trading on Wednesday, reaching $383.55. 463,841 shares of the company's stock traded hands, compared to its average volume of 1,435,693. The company has a market cap of $92.27 billion, a price-to-earnings ratio of 17.46, a PEG ratio of 1.10 and a beta of 1.46. The stock has a 50 day moving average of $353.00 and a two-hundred day moving average of $330.71. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.75 by $0.70. The company had revenue of $18.32 billion for the quarter, compared to the consensus estimate of $18.26 billion. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. HCA Healthcare's revenue was up 5.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $5.36 earnings per share. Equities analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Monday, June 16th will be paid a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.75%. The ex-dividend date is Monday, June 16th. HCA Healthcare's dividend payout ratio is currently 12.81%.

Analysts Set New Price Targets

HCA has been the topic of a number of recent analyst reports. Royal Bank of Canada cut their price target on shares of HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating on the stock in a report on Monday, April 28th. Baird R W cut shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Wells Fargo & Company raised shares of HCA Healthcare from an "underweight" rating to an "equal weight" rating and boosted their price objective for the company from $320.00 to $385.00 in a report on Thursday, May 29th. Barclays boosted their price objective on shares of HCA Healthcare from $366.00 to $416.00 and gave the company an "overweight" rating in a report on Monday. Finally, Wall Street Zen upgraded shares of HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Monday, April 28th. Seven investment analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $388.80.

Insider Activity

In other news, COO Jon M. Foster sold 15,698 shares of the company's stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the transaction, the chief operating officer now directly owns 12,646 shares in the company, valued at approximately $4,670,420.72. This represents a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 1.30% of the company's stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.